Zhoushan Huakang Biotechnology Co., Ltd. announced that it will receive CNY 700,000,000 in an equity round of funding on January 3, 2024. The transaction will include participation from returning investor Zhejiang Huakang Pharmaceutical Co., Ltd. to retain the majority stake in the company. The registered capital of the company is CNY 300,000,000.

Post-completion of the transaction, the registered capital of the company will increase from CNY 300,000,000 to CNY 1,000,000,000. The transaction has been approved in the 11th Meeting of the 6th Directorate and the 10th Meeting of the 6th Supervisory Board of the investor's company and does not need the shareholders? approval.